From product opportunity to verified partner shortlist
Evimple helps pharma teams evaluate opportunities, reduce risks, and find the right partners faster.
All of it in one place.
Trusted by companies already on the platform
Research, decide, then partner - in one place
Without Evimple: slow assessments, manual partner search, missed opportunities. With Evimple: faster evaluation, validated risks, verified partners, clear next steps.
Scattered workflow
Three databases, spreadsheets, and internal loops - but no clear go/no-go decision.
Patent, regulatory, market, and competitive risks sit in separate sources.
CDMO, CMO, CRO, and supplier searches depend on scraped lists or cold emails.
Licensing and portfolio opportunities are evaluated ad hoc, one by one.
Partner conversations start too late - or never.
One workspace
Start with a real use case: partner search, portfolio gap, product assessment, or licensing target.
Receive a business-ready opportunity brief with go/no-go, risks, evidence, and next action.
Validate patent, FTO, regulatory, market, and partner availability before committing.
Find verified CDMO, CMO, CRO, supplier, and licensing contacts with fit rationale.
Spend the rest of the month on negotiations, partnerships, and strategic execution.
Four pharma BD workflows Evimple supports
Start with one real business development or licensing task. Evimple returns a structured answer your team can act on.
Partner search
Find the right CDMO, CMO, CRO, supplier, or analytical lab for a specific product.
Output: Verified partner shortlist with fit rationale, contacts, and outreach angle.
Portfolio expansion
Identify which products or molecules are worth adding to your pipeline.
Output: Ranked opportunities with portfolio fit, risks, and partner availability.
Opportunity assessment
Decide whether to pursue an innovative product, generic or biosimilar.
Output: Go/no-go brief with evidence, risk view, partner strategy, and next action.
Licensing discovery
Find license-in targets that match your commercial strategy or suitable territories for license-out opportunities.
Output: Matched assets and companies with fit rationale, risk flags, and outreach targets.
Built by pharma experts for pharma experts
Built for pharma business development, portfolio, sourcing and licensing teams: from product assessment to partner search and outreach.
Pharmaceutical companies
Accelerate your portfolio growth
CDMOs & CMOs
Find new clients and scale up your business
Drug developers
Collaborate and License-out your assets
CROs & Analytical laboratories
Connect with new clients efficiently
Built for the questions pharma teams already ask when assessing products and partners
These are the high-intent workflows Evimple is designed to answer for small and mid-size pharma, biotech, generics, biosimilar, and specialty pharma teams.
We're evaluating a product - should we move forward?
Evimple turns molecule and product evaluation into a BD-ready opportunity brief with medical, patent, regulatory, market, and partner evidence, so teams can move from scattered research to a go/no-go recommendation.
We need to find the right partner for this product.
Use Evimple to define the product, dosage form, geography, timeline, and capability needs, then receive a verified CDMO, CMO, CRO, or supplier shortlist with fit rationale and contacts.
We need to grow our portfolio but don't know what to prioritize.
Evimple helps compare product and molecule opportunities by portfolio fit, market attractiveness, patent and regulatory risk, partner availability, and next action.
How do I find license-in or license-out targets?
Evimple matches licensing criteria to indexed opportunities, target companies, assets, risk flags, and outreach targets for pharma and biotech business development teams.
Stop wasting pharma talent on fruitless searches and endless emails.
Bring a molecule, product, portfolio gap, partner search, or licensing target. Evimple turns it into an opportunity brief, verified shortlist, and next action.
Talk to us